SWM
COLL icon

Spire Wealth Management’s Collegium Pharmaceutical COLL Stock Holding History

Spire Wealth Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.1K Buy
1,301
+1,001
+334% +$34.2K ﹤0.01% 1194
2026
Q1 		$9.92K Sell
300
-300
-50% -$12.7K ﹤0.01% 1616
2025
Q4 		$27.8K Hold
600
– – ﹤0.01% 1360
2025
Q3 		$21K Sell
600
-181
-23% -$6.29K ﹤0.01% 1517
2025
Q2 		$23.1K Buy
781
+14
+2% +$399 ﹤0.01% 1464
2025
Q1 		$22.9K Buy
767
+167
+28% +$5.1K ﹤0.01% 1561
2024
Q4 		$17.2K Buy
+600
New +$19.9K ﹤0.01% 1668

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Spire Wealth Management's COLL Position: Q2 2026 in Review

Spire Wealth Management increased its Collegium Pharmaceutical (COLL) stake by 334% in Q2 2026, buying an estimated $34.2K and bringing the position to 1,301 shares worth $47.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1194.

Spire Wealth Management first reported a position in COLL in Q4 2024 and has held it in 7 quarters since. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Spire Wealth Management held 1,301 shares of Collegium Pharmaceutical worth $47.1K as of Q2 2026.
  • Spire Wealth Management bought 1,001 Collegium Pharmaceutical shares in Q2 2026, an estimated $34.2K.
  • Collegium Pharmaceutical made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #1194 holding.
  • Spire Wealth Management first reported a position in Collegium Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.